Gilead's faces criticism over effectiveness, pricing and US government support of remdesivir

Article discusses WHO’s SOLIDARITY clinical trial that did not find effect on survival, the high price of the drug, other therapies, including dexamethasone, which appear to be at least as or more effective, and potential elimination of its market if a vaccine is approved.

Source:

Biospace Inc.